Concepedia

Sarah Carpenter

SC

Statistics

Publications

6

Citations

210

H-Index

6

Active since

1989

Affiliations

Elusys Therapeutics (United States)(Current)

Battelle

Duke Medical Center

Sarah Carpenter is an author at Elusys Therapeutics (United States) specializing in medicine, immunology, and antimicrobial resistance.

Top concepts

Publications per year

1989–2017

6

Publications

6

Vancomycin-associated linear IgA dermatosis

Sarah Carpenter, Daniel Berg, Navjeet Sidhu‐Malik et al. · Journal of the American Academy of Dermatology · 1992 · 82 citations

, , +7

Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax

Brent Yamamoto, Annette M. Shadiack, Sarah Carpenter et al. · Antimicrobial Agents and Chemotherapy · 2016 · 46 citations · Full text

, , +14

Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity

Brent Yamamoto, Annette M. Shadiack, Sarah Carpenter et al. · Antimicrobial Agents and Chemotherapy · 2016 · 33 citations · Full text

, , +17

Pharmacokinetics and Tolerability of Obiltoxaximab: A Report of 5 Healthy Volunteer Studies

Christa F. Nagy, Timothy Leach, Joseph H. Hoffman et al. · Clinical Therapeutics · 2016 · 21 citations · Full text

Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen

Lisa N. Henning, Sarah Carpenter, Gregory V. Stark et al. · Antimicrobial Agents and Chemotherapy · 2017 · 18 citations · Full text

1–5 of 6